Diabetes Research and Clinical Practice
Volume 72, Issue 1 , Pages 28-32 , April 2006

Serum cholinesterase activity in diabetes and associated pathologies

  • Gilberto Inácio Lunkes

      Affiliations

    • Departamento de Ciências da Saúde, Universidade de Cruz Alta, Cruz Alta, RS, Brazil
    • ,
  • Franciele Stefanello

      Affiliations

    • Departamento de Química, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS, Brazil
    • ,
  • Daniéle Sausen Lunkes

      Affiliations

    • Departamento de Ciências da Saúde, Universidade de Cruz Alta, Cruz Alta, RS, Brazil
    • ,
  • Vera Maria Morsch

      Affiliations

    • Departamento de Química, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS, Brazil
    • ,
  • Maria Rosa Chitolina Schetinger

      Affiliations

    • Departamento de Química, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS, Brazil
    • Corresponding Author InformationCorresponding author. Fax: +55 5522 08031.
    • ,
  • Jamile Fabbrin Gonçalves

      Affiliations

    • Departamento de Química, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, 97105-900 Santa Maria, RS, Brazil

Received 17 February 2005 ,Revised 24 August 2005 ,Accepted 30 August 2005.

References 

  1. Osmundson PJ, O’Fallon M, Zimmerman BR, et al. Course of peripheral occlusive arterial disease in diabetes: vascular laboratory assessment. Diab. Spectr. 1991;4:330–340
  2. Matsumoto K, Kizaki Y, Fukae S, et al. Insulin resistance and coronary risk factors in Japanese type 2 diabetic patients with definitive coronary artery disease. Diab. Res. Clin. Pract. 2001;51:181–186
  3. Tan CE, Chew LS, Chio LF, et al. Cardiovascular risk factors and LDL subfraction profile in type 2 diabetes mellitus subjects with good glycemic control. Diab. Res. Clin. Pract. 2001;51:107–114
  4. Suzuki M, Takamisawa I, Suzuki K, et al. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension. Am. J. Hypertens. 2004;17:228–232
  5. Massoulié J, Pezzementi L, Bom S, Krejci E. Molecular and cellular biology of cholinesterase. Prog. Neurobiol. 1993;41:31–41
  6. Hijikata-Okunomiya O, Okamoto S, Tamao Y, et al. N-Dansyl-l-arginine4-phenylpiperidine amide: a potent and selective inhibitor of horse serum cholinesterase. J. Biol. Chem. 1988;23:269–273
  7. Müller TC, Rocha JBT, Morsch VM, et al. Antidepressants inhibit human acetylcholisterase and butyrylcholinesterase activity. Biochim. Biophys. Acta. 2002;1587:92–98
  8. Lockridge O. Structure of human serum cholinesterase. Bioessays. 1988;9:125–128
  9. Mehrani H. Simplified procedures for purification and stabilization of human plasma butyrylcholinesterase. Proc. Biochem. 2004;39:877–882
  10. Ragoobirsingh D, Bharaj BS, Morrison EY. Change in serum cholinesterase activity in Jamaican diabetes. J. Natl. Med. Assoc. 1992;84:853–855
  11. Abbott CA, Mackness MI, Kumar S, et al. Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus. Clin. Sci. 1993;85:77–81
  12. Rustemeijer C, Schouten JA, Voerman HJ, et al. Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus?. Clin. Sci. 2001;101:29–35
  13. Kalman J, Juhasz A, Rakonczay Z, et al. Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients. Life Sci. 2004;75:1195–1204
  14. Alcantara VM, Chautard-Freire-Maia EA, Scartezini M, et al. Butyrylcholinesterase activity and risk factors for coronary artery disease. Scand. J. Clin. Lab. Invest. 2002;62:399–404
  15. Ellman GC, Courtney KD, Andres V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961;7:88–95
  16. Rocha JBT, Emanuelli T, Pereira ME. Effects of early undernutrition on kinetic parameters of brain acetylcholinesterase from adult rats. Acta Neurobiol. Exp. 1993;53:431–437
  17. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976;72:248–254
  18. Cucuianu M, Nistor T, Hancu N, et al. Serum cholinesterase activity correlates with serum insulin, C-peptide and free fatty acids levels in patients with type 2 diabetes. Rom. J. Intern. Med. 2002;40:43–51
  19. Randell EW, Mathews MS, Zhang H, et al. Relationship between serum butyrylcholinesterase and the metabolic syndrome. Clin. Biochem. 2005;38:799–805
  20. Patel BN, Mackness MI, Harty DW, et al. Serum esterase activities and hyperlipidemia in the streptozotocin-diabetic rat. Biochim. Biophys. Acta. 1990;1035:113–116
  21. Dave KR, Katyare SS. Effect of alloxan-induced diabetes on serum and cardiac butyrylcholinesterase in the rat. Endocrinology. 2002;175:241–250
  22. Kutty KM, Payne RH. Serum cholinesterase and very-low-density lipoprotein metabolism. J. Clin. Lab. Anal. 1994;8:246–250
  23. Randell EW, Rogers B, Smith E. Production of butyrylcholinesterase by CaCo-2 cells: lack of relationship with triglyceride production. Cell. Mol. Life. 2001;58:1327–1332
  24. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr. Ver. 2001;22:36–52
  25. Gomes MB, Affonso FS, Cailleaux S, et al. Glucose levels observed in daily clinical practice induce endothelial dysfunction in the rabbit macro-and microcirculation. Fundam. Clin. Pharmacol. 2004;18:339–346

PII: S0168-8227(05)00362-1

doi: 10.1016/j.diabres.2005.08.009

Diabetes Research and Clinical Practice
Volume 72, Issue 1 , Pages 28-32 , April 2006

Article Tools

* Image Usage & Resolution